End-stage renal disease predicts complications in pacemaker and ICD implants

Journal of Cardiovascular Electrophysiology

Volumn 22, Issue 10, 2011, Pages 1099-1104

  Tompkins, Christine ^a   McLean, Rhondalyn ^b   Cheng, Alan ^b   Brinker, Jeffrey A ^b   Marine, Joseph E ^b   Nazarian, Saman ^b   Spragg, David D ^b   Sinha, Sunil ^b   Halperin, Henry ^b   Tomaselli, Gordon F ^b   Berger, Ronald D ^b   Calkins, Hugh ^b   Henrikson, Charles A ^b  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^b DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

chronic kidney disease; heart failure; implantable cardioverter defibrillator; infection; pacemaker

Indexed keywords

ACETYLSALICYLIC ACID; CEFAZOLIN; CEPHALOSPORIN; CLINDAMYCIN; CLOPIDOGREL; HEPARIN; NEOMYCIN; PENICILLIN G; POLYMYXIN B; VANCOMYCIN; WARFARIN;

ADULT; AGED; ARTICLE; ARTIFICIAL HEART PACEMAKER; BACTEREMIA; BLEEDING; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; DEFIBRILLATOR; FEMALE; GLOMERULUS FILTRATION RATE; HEART TAMPONADE; HEMATOMA; HOSPITALIZATION; HUMAN; KIDNEY FAILURE; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; POSTOPERATIVE COMPLICATION; PREDICTION; PRIORITY JOURNAL; SEPSIS;

ADULT; AGED; AGED, 80 AND OVER; BALTIMORE; COMMUNICABLE DISEASES; DEFIBRILLATORS, IMPLANTABLE; FEMALE; GLOMERULAR FILTRATION RATE; HEART FAILURE; HEMORRHAGE; HUMANS; KIDNEY; KIDNEY FAILURE, CHRONIC; LOGISTIC MODELS; MALE; MIDDLE AGED; ODDS RATIO; PACEMAKER, ARTIFICIAL; PATIENT SELECTION; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TREATMENT OUTCOME;

EID: 80051943886     PISSN: 10453873     EISSN: 15408167     Source Type: Journal    
DOI: 10.1111/j.1540-8167.2011.02066.x     Document Type: Article

References (39)

1. Zakeri R,;, Freemantle N, Barnett V, Lipkin GW, Bonser RS, Graham TR, Rooney SJ, Wilson IC, Cramb R, Keogh BE, Pagano D,: Relation between mild renal dysfunction and outcomes after coronary artery bypass grafting. Circulation 2005; 112: I-270-I-275.
2. Anavekar NS, McMurray JV, Velazquez EJ, Solomon SD, Kober L, Rouleau JL, White HD, Nordlander R, Maggioni A, Dickstein K, Zelenkofske S, Leimberger JD, Califf RM, Pfeffer MA,: Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction. N Engl J Med 2004; 351: 1285-1295. (Pubitemid 39258422)
3. Fox KAA, Antman EM, Montalescot G, Agewall S, SomaRaju B, Verheugt FWA, Lopez-Sendon J, Hod H, Murphy SA, Braunwald E,: The impact of renal dysfunction on outcomes in the ExTRACT-TIMI 25 trial. J Am Coll Cardiol 2007; 49: 2249-2255. (Pubitemid 46863477)
4. Chertow GM, Lazarus JM, Christiansen CL, Cook EF, Hammermeister KE, Grover F, Daley J,: Preoperative renal risk stratification. Circulation 1997; 95: 878-884. (Pubitemid 27091528)
5. Medi C, Montalescot G, Budaj A, Fox KAA, Lõpez-Sendõn J, FitzGerald G, Brieger DB, on behalf of the GRACE Investigators: Reperfusion in patients with renal dysfunction after presentation with ST-segment elevation or left bundle branch block: GRACE (Global Registry of Acute Coronary Events). JACC Cardiovasc Interv 2009; 2: 26-33.
6. Schiffrin EL, Lipman ML, Mann JF,: Chronic kidney disease: Effects on the cardiovascular system. Circulation 2007; 116: 85-97. (Pubitemid 47016250)
7. Bloom H, Heeke B, Leon A, Mera F, Delurgio D, Beshai J, Langberg J,: Renal insufficiency and the risk of infection from pacemaker or defibrillator surgery Pacing Clin Electrophysiol 2006; 29: 142-145.
8. Moss AJ, Hall WJ, Cannom DS, Klein H, Brown MW, Daubert JP, Estes III NA, Foster E, Greenberg H, Higgins SL, Pfeffer MA, Solomon SD, Wilber D, Zareba W, for the MADIT-CRT Trial Investigators: Cardiac-resynchronization therapy for the prevention of heart-failure events. N Engl J Med 2009; 361: 1329-1338.
9. Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R, Domanski M, Troutman C, Anderson J, Johnson G, McNulty SE, Clapp-Channing N, Davidson-Ray LD, Fraulo ES, Fishbein DP, Luceri RM, Ip JH, for the sudden cardiac death in heart failure trial (SCD-HeFT) investigators. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 2005; 352: 225-237. (Pubitemid 40110811)
10. Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS, Daubert JP, Higgins SL, Brown MW, Andrews ML, for the multicenter automatic defibrillator implantation trial II investigators (MADIT II). Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002; 346: 877-883. (Pubitemid 34984635)
11. Lamas GA, Lee KL, Sweeney MO, Silverman R, Leon A, Yee R, Marinchak RA, Flaker G, Schron E, Orav EJ, Hellkamp AS, Greer S, McAnulty J, Ellenbogen K, Ehlert F, Freedman RA, Estes III NA, Greenspon A, Goldman L, for the mode selection trial in sinus-node dysfunction (MOST). Ventricular pacing or dualcChamber pacing for sinus-node dysfunction. N Engl J Med 2002; 346: 1854-1862. (Pubitemid 34603029)
12. Eknoyan G, Levin NW,: K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification. Am J Kidney Diseases 2002; 39: S1-S266.
13. Cockcroft DW, Gault MH,: Prediction of creatinine clearance from serum creatinine. Nephron 1976; 16: 31-41.
14. Tompkins C, Cheng A, Dalal D, Brinker JA, Leng CT, Marine JE, Nazarian S, Spragg DD, Sinha S, Halperin H, Tomaselli GF, Berger RD, Calkins H, Henrikson CA,: Dual antiplatelet therapy and heparin "bridging" significantly increase the risk of bleeding complications after pacemaker or implantable cardioverter-defibrillator device implantation. J Am Coll Cardiol 2010; 55: 2376-2382.
15. Calkins H, Ramza BM, Brinker J, Atiga W, Donahue K, Nsah E, Taylor E, Halperin H, Lawrence JH, Tomaselli G, Berger RD,: Prospective randomized comparison of the safety and efficacy of placement of endocardial pacemaker and defibrillator leads using the extrathoracic subclavian vein guided by contrast venography versus the cephalic approach. Pacing Clin Electrophysiol 2001; 24: 456-464. (Pubitemid 32374866)
16. Anderson JL, Adams CD, Antman EM, Bridges CR, Califf RM, Casey DE, Chavey II WE, Fesmire FM, Hochman JS, Levin TN, Lincoff AM, Peterson ED, Theroux P, Wenger NK, Wright RS,: ACC/AHA 2007 guidelines for the management of patients with unstable angina/non- ST-elevation myocardial infarction. J Am Coll Cardiol 2007; 50: e1-e157.
17. Mehta RH, Roe MT, Mulgund J, Ohman EM, Cannon CP, Gibler WP, Pollack CV, Smith SC, Ferguson TB, Peterson ED,: Acute clopidogrel use and outcomes in patients treated with non-ST-segment elevation acute coronary syndromes undergoing CABG. J Am Coll Cardiol 2006; 48: 281-6.
18. Hirsh J, Fuster V, Ansell J, Halperin JL,: AHA/ACC foundation guide to warfarin therapy. J Am Coll Cardiol 2003; 41: 1633-52.
19. Goldhaber SZ,: Low intensity warfarin anticoagulation is safe and effective as a long-term venous thromboembolism prevention strategy. J Thromb Thrombolysis 2006; 21: 51-52. (Pubitemid 43231128)
20. Rath CE, Mailliard JA, Schreiner GE,: Bleeding tendency in uremia. N Engl J Med 1957; 257: 808-811.
21. Ibanez J, Riera M, Saez de Ibarra JI, Carrillo A, Fernandez R, Herrero J, Fiol M, Bonnin O,: Effect of preoperative mild renal dysfunction on mortality and morbidity following valve cardiac surgery. Interact Cardiovasc Thoracic Surg 2007; 6: 748-752. (Pubitemid 350291691)
22. Anderson RJ, O'Brien M, MaWhinney S, VillaNueva CB, Moritz TE, Sethi GK, Henderson WG, Hammermeister KE, Grover FL, Shroyer AL, The participants of VA cooperative study #5. Renal failure predisposes patients to adverse outcome after coronary artery bypass surgery. Kidney Int 1999; 55: 1057-1062. (Pubitemid 29100719)
23. Hamdan AD, Pomposelli FB, Gibbons GW, Campbell DR, LoGerfo FW,: Renal insufficiency and altered postoperative risk in carotid endarterectomy. J Vasc Surg 1999; 29: 1006-1011. (Pubitemid 29284357)
24. Galbusera M, Remuzzi G, Boccardo P,: Treatment of bleeding in dialysis patients. Semin Dial 2009; 22: 279-86.
25. Gangji AS, Sohal AS, Treleaven D, Crowther MA,: Bleeding in patients with renal insufficiency: A practical guide to clinical management. Thromb Res 2006; 118: 423-428. (Pubitemid 44067194)
26. Voigt A, Shalaby A, Saba SF,: Rising rates of cardiac rhythm management device infections in the US 1996-2003. J Am Coll Cardiol 2006; 48: 590-591. (Pubitemid 44093958)
27. Khan AH, Sohail MR, Friedman PA, Hayes DL, Wilson WR, Steckelberg JM, Stoner S, Hodge DO, Baddour LM,: Abstract P1-57: Pacemaker and ICD infections: Risk factor analysis using a case-control design. Heart Rhythm 2006; 3: S126.
28. Montgomerie JZ, Kalmanson GM, Guze LB,: Renal failure and infection. Medicine 1968; 47: 1-32.
29. Kato S, Chmielewski M, Honda H, Pecoits-Filho R, Matsuo S, Yuzawa Y, Tranaeus A, Stenvinkel P, Lindholm B,: Aspects of immune dysfunction in end-stage renal disease. Clin J Am Soc Nephrol 2008; 3: 1526-33.
30. Sarnak MJ, Jaber BL,: Mortality caused by sepsis in patients with end-stage renal disease compared with the general population. Kidney Int 2000; 58: 1758-1764.
31. Hoen B, Paul-Dauphin A, Hestin D, Kessler M,: EPIBACDIAL: A multicenter prospective study of risk factors for bacteremia in chronic hemodialysis patients. J Am Soc Nephrol 1998; 9: 869-876.
32. Cacoub P, Leprince P, Nataf P, Hausfater P, Dorent R, Wechsler B, Bors V, Pavie A, Piette JC, Gandjbakhch I,: Pacemaker infective endocarditis. Am J Cardiol 1998; 82: 480-484. (Pubitemid 28389947)
33. Baddour LM, Epstein AE, Erickson CC, Knight BP, Levison ME, Lockhart PB, Masoudi FA, Okum EJ, Wilson WR, Beerman LB, Bolger AF, Estes NA III, Gewitz M, Newburger JW, Schron EB, Taubert KA,: Update on cardiovascular implantable electronic device infections and their management: A scientific statement for the American Heart Association. Circulation 2010; 121: 458-477.
34. de Oliveira JC, Martinelli M, D'Orio Nishioka SA, Varejão T, Uipe D, Andrade Pedrosa AA, Costa R, Danik SB,: Efficacy of antibiotic prophylaxis before the implantation of pacemakers and cardio-defibrillators. Circ Arrhythmia Electrophysiol 2009; 2: 29-34.
35. Da Costa A, Kirkorian G, Cucherat M, Delahaye F, Chevalier P, Cerisier A, Isaaz K, Touboul P,: Antibiotic prophylaxis for permanent pacemaker implantation: a meta-analysis. Circulation 1998; 97: 1796-1801. (Pubitemid 28213623)
36. PIVIT™ CRM by TyRx Pharma. © 2007 Data on line at.
37. Hansen LK, Brown M, Johnson D, Palme DF, Love C, Darouiche R,. In vivo model of human pathogen infection and demonstration of efficacy by an anti-microbial pouch for pacing devices. PACE 2009; 32: 898-907.
38. Bardy GH, Smith WM, Hood MA, Crozier IG, Melton IC, Jordaens L, Theuns D, Park RE, Wright DJ, Connelly DT, Fynn SP, Murgatroyd FD, Sperzel J, Neuzner J, Spitzer SG, Ardashev AV, Oduro A, Boersma L, Maass AH, Van Gelder IC, Wilde AA, van Dessel PF, Knops RE, Barr CS, Lupo P, Cappato R, Grace AA,: An entirely subcutaneous implantable cardioverter-defibrillator. N Engl J Med 2010; 363: 36-44.
39. Silverman SL,: From randomized controlled trials to observational studies. Am J Med 2009; 122: 114-20.